Jan 30, 2019

For the January Journal Club, we will be taking a look at the recent human senolytics trial conducted at the Mayo Clinic

Posted by in category: biotech/medical


Justice, J. N., Nambiar, A. M., Tchkonia, T., LeBrasseur, N. K., Pascual, R., Hashmi, S. K., … & Kirkland, J. L. (2019). Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study. EBioMedicine.

Read more

Comments are closed.